Analysts think CLGN stock price could increase by 162%
Aug 02, 2024, 6:25 AM
26.87%
What does CLGN do
CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine company that develops technologies and products for tissue regeneration and organ production. Their innovations are centered on plant-based collagen type I (rhCollagen).
3 analysts think CLGN stock price will increase by 162.15%. The current median analyst target is $11.22 compared to a current stock price of $4.28. The lowest analysts target is $11.11 and the highest analyst target is $11.55.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
